Add Company
Join Now

Seneca Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Seneca Therapeutics's estimated annual revenue is currently $1.9M per year.(i)
  • Seneca Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Seneca Therapeutics has 12 Employees.(i)
  • Seneca Therapeutics grew their employee count by 0% last year.

Seneca Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Founder, President, Chief Scientific OfficerReveal Email/Phone
3
Human Resources and Business Operations Manager at Seneca Therapeutics, Inc.Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Seneca Therapeutics?

Seneca Therapeutics was found by Dr. Paul Hallenbeck to develop the Seneca Valley Virus (“SVV-001”), a best in class oncolytic virus. SVV-001 is already in Phase I/II and has a clinical safety record in humans. SVV-001 binds to the TEM8 receptor which is common in many solid tumors like breast cancer, lung cancer and neuroendocrine tumors. SVV-001 is also being considered as a viral vector for gene therapy targeting the TEM8 receptor in solid tumors.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M120%N/A
#2
$1M129%N/A
#3
$0.9M120%N/A
#4
$1.5M12-48%N/A
#5
$7.5M129%N/A